Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kala Azar”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00973128
What this trial is testing

Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Hospital Universitário Professor Edgard Santos 40
Large-scale testing (Phase 3)Study completedNCT00351520
What this trial is testing

Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica

Who this might be right for
Cutaneous Leishmaniasis
Tehran University of Medical Sciences 148
Testing effectiveness (Phase 2)Study completedNCT01845727
What this trial is testing

Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia

Who this might be right for
Cutaneous Leishmaniasis
Drugs for Neglected Diseases 80
Testing effectiveness (Phase 2)Study completedNCT00662012
What this trial is testing

Sodium Stibogluconate Treatment of Leishmaniasis

Who this might be right for
Leishmaniasis
U.S. Army Medical Research and Development Command 414
Not applicableUnknownNCT03009422
What this trial is testing

Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.

Who this might be right for
Leishmaniasis
Tel-Aviv Sourasky Medical Center 20
Not applicableUnknownNCT05386875
What this trial is testing

Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 625
Not applicableEnded earlyNCT03013673
What this trial is testing

Predicting Visceral Leishmaniasis in HIV Infected Patients

Who this might be right for
Leishmaniasis, Visceral
Institute of Tropical Medicine, Belgium 566
Large-scale testing (Phase 3)Study completedNCT00628719
What this trial is testing

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 400
Testing effectiveness (Phase 2)Study completedNCT06449040
What this trial is testing

Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 28
Testing effectiveness (Phase 2)Ended earlyNCT01140191
What this trial is testing

Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis

Who this might be right for
Leishmaniasis, Cutaneous
U.S. Army Medical Research and Development Command 1
Not applicableStudy completedNCT01328457
What this trial is testing

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

Who this might be right for
Visceral Leishmaniasis
PATH 120
Not applicableStudy completedNCT05449717
What this trial is testing

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Who this might be right for
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Epicentre 52
Testing effectiveness (Phase 2)UnknownNCT03399955
What this trial is testing

Short Course Regimens for Treatment of PKDL (Sudan)

Who this might be right for
PKDL - Post-Kala-Azar Dermal Leishmanioid
Drugs for Neglected Diseases 110
Early research (Phase 1)Study completedNCT00486382
What this trial is testing

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Who this might be right for
Visceral LeishmaniasisPost-kala-azar Dermal Leishmaniasis
Access to Advanced Health Institute (AAHI) 36
Early research (Phase 1)Ended earlyNCT04504435
What this trial is testing

Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants

Who this might be right for
Leishmaniasis
GlaxoSmithKline 59
Not applicableStudy completedNCT04841239
What this trial is testing

Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis

Who this might be right for
Leishmaniasis, Cutaneous
Jinnah Sindh Medical University 78
Not applicableWithdrawnNCT02429505
What this trial is testing

Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

Who this might be right for
Leishmaniasis
Knight Therapeutics (USA) Inc
Testing effectiveness (Phase 2)Study completedNCT01988909
What this trial is testing

WR 279,396 for the Treatment of Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Assistance Publique - Hôpitaux de Paris 18
Testing effectiveness (Phase 2)Study completedNCT00996463
What this trial is testing

Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients

Who this might be right for
Wound Healing
Waisenmedizin e. V. Promoting Access to Essential Medicine 63
Not applicableStudy completedNCT00310505
What this trial is testing

Amphotericin B Treatment in Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 1,500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation